Strategies for Improving the Quantitative Bioanalytical Performance of LC-MS in Pharmacokinetic Studies

Author(s): Li Li, Dandan Tian, Feng Chen, Junling Yang, Ke Yu, Yan Sun

Journal Name: Current Drug Metabolism

Volume 13 , Issue 9 , 2012

Become EABM
Become Reviewer
Call for Editor


Quantitative bioanalysis is urgently required for the evaluation of pharmacokinetic properties of a drug and to demonstrate the body exposure to the parent drug and/or metabolite for interpretation of the efficacy and toxicity. New trends in drug discovery and development will be always posing challenges on LC–MS-based quantitative bioanalysis. The focus of this minireview is to highlight the commonly used strategies for improving the quantitative bioanalytical performance including overcoming matrix effects and improving MS detectability. “LC-electrolyte effects” and “pulse gradient chromatography” proposed by our group are new approaches that have also showed potential efficiencies on improving overall bioassay performance, including lowering lower limit of quantification (LLOQ), enlarging upper limit of quantification (ULOQ), decreasing matrix effects, and overcoming elutropic effects, etc.. They should also work well in metabolic profiling studies and other important analytical fields, such as food pesticide residue analysis, environmental analysis, clinical and forensic toxicology, doping control, and so on.

Keywords: Pharmacokinetics, LC–MS, matrix effects, sensitivity enhancement, LC-electrolyte effects, pulse gradient chromatography

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [1206 - 1212]
Pages: 7
DOI: 10.2174/138920012803341320
Price: $65

Article Metrics

PDF: 35